US 9327023
HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9327023 (HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/337, A61K31/685